Azione 2O9 RENALYTIX PLC
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Renalytix Plc Deutsche Boerse AG

Azioni

2O9

GB00BYWL4Y04

Mercato chiuso - Deutsche Boerse AG
Altri mercati azionari
 15:29:01 25/06/2024 		Variaz. 5gg Var. 1 gen.
0,161 EUR -14,81% Grafico intraday di Renalytix Plc -22,60% -13,90%
25/06 Le azioni di Renalytix crollano per la possibile sospensione delle ADS sul Nasdaq AN
25/06 Renalytix farà ricorso contro il delisting dal Nasdaq per non conformità MT

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Shares in Renalytix plunge on possible ADS suspension on Nasdaq
Renalytix to Appeal Nasdaq Delisting Over Non-compliance
Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination
Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test
Shares in Renalytix jump as Medicare issues LCD for kidneyintelX.dkd
Certain Ordinary Shares of Renalytix Plc are subject to a Lock-Up Agreement Ending on 11-JUN-2024.
Renalytix Files Registration Statement on Behalf of Selling Shareholders
EXECUTIVE CHANGES: Resolute Mining hires former Acacia exec as chair
Renalytix Plc Designates Joel R. Jung as Principal Accounting Officer
Renalytix CFO Steps Down; Interim Successor Named
Renalytix plc Announces Chief Financial Officer Changes
Renalytix Plans to Sell American Depositary Shares for Up to $15 Million
Vertu Motors ups dividend as hails record revenue
Earnings Flash (RNLX) RENALYTIX Reports Q3 Revenue $535,000
Renalytix Plc Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Renalytix Plc Reports Impairment Loss on Property, Equipment and Other Long-Lived Assets for the Third Quarter Ended March 31, 2024
Pentwater Capital Management LP - Form 8.3 - Renalytix PLC
Renalytix chief business officer to become president
Renalytix Names Chief Business Officer as President
Renalytix plc Announces Executive Changes, Effective from April 30, 2024
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione RENX
  4. Azione 2O9
  5. Notizie Renalytix Plc
  6. Altre lingue